SLC2A1 and hepatocellular carcinoma: Elevated expression of glucose transporter 1 (GLUT1) is commonly observed in HCC and is associated with poorer patient prognosis (23, 24), largely due to its correlation with TP53 mutations and activation of the PI3K/AKT/mTOR signaling pathway (25).